Author:
Wu Yuanbing,Jiang Shanshan,Li Dongyang,Wu Yaxue,Li Qian,Wang Xing,Liu Bin,Bao Haiyan,Wu Depei,Hu Xiaohui
Funder
Su Zhou Industrial Park He He Yuan Da Blood Innovation Research Institute
Innovative and Applied Scientific Research Project of Professional Ability of Clinical Specialists
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Reference45 articles.
1. Averbuch D, Tridello G, Hoek J, et al. Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the european bone marrow transplantation group. Clin Infect Dis. 2017;65(11):1819–28.
2. Zeng M, Xia J, Zong Z, et al. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect. 2023;S1684–1182(23):00036–41.
3. Loon KV, Voor in ‘T Holt AF, Vos MC. A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2018;62(1):e01730-e11717.
4. Micozzi A, Gentile G, Minotti C, et al. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect Dis. 2017;17(1):203.
5. Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274–83.